Sol-Gel Technologies (SLGL) EPS (Basic) (2017 - 2026)
Sol-Gel Technologies' (SLGL) quarterly EPS (Basic) came in at $1.31 in Q1 2026, down 58.45% year-on-year from $3.16 in Q1 2025, and up 105.91% on a QoQ basis from -$22.22 in Q4 2025.
Sol-Gel Technologies (SLGL) EPS (Basic) (2017 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 10 years of EPS (Basic) data on file, last reported at $1.31 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 58.45% year-over-year to $1.31 in Q1 2026; TTM through Mar 2026 was -$18.77, a 12.97% decrease from a year earlier, with the FY2025 full-year figure at -$23.71, down 6.85% from the prior year.
- EPS (Basic) for Q1 2026 stood at $1.31, up from -$22.22 in the prior quarter.
- Over the last five years, EPS (Basic) for SLGL reached as high as $4.3 in Q1 2023 and fell as low as -$22.22 in Q4 2025.
- Historically, EPS (Basic) has averaged -$4.02 across 5 years, with a median of $0.06 in 2022.
- Across the five-year window, EPS (Basic) sank 8320565574.44% in 2022 and soared 3625.27% in 2023, its largest moves.
- Year by year, EPS (Basic) stood at -$22.01 in 2022, then advanced by 10.55% to -$19.68 in 2023, then fell by 1.92% to -$20.06 in 2024, then slipped by 10.78% to -$22.22 in 2025, then surged by 105.91% to $1.31 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were $1.31 in Q1 2026, -$22.22 in Q4 2025, and -$2.26 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Sol-Gel Technologies | 234.04 Mn | 223.91 Mn | - | 1.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 |
| Dec 31, 2025 | -22.22 |
| Sep 30, 2025 | -2.26 |
| Jun 30, 2025 | 4.03 |
| Mar 31, 2025 | 3.16 |
| Dec 31, 2024 | -20.06 |
| Sep 30, 2024 | -0.30 |
| Jun 30, 2024 | 0.58 |
| Mar 31, 2024 | 2.28 |
| Dec 31, 2023 | -19.68 |
| Sep 30, 2023 | -2.05 |
| Jun 30, 2023 | 2.16 |
| Mar 31, 2023 | 4.30 |
| Dec 31, 2022 | -22.01 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.06 |
| Mar 31, 2022 | 2.42 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 3.49 |